(ENTX) |
| 0 (0%) 05-29 22:43 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.60 |
| Resistance 1: | 1.37 |
| Pivot price: | 1.25 |
| Support 1: | 1.18 |
| Support 2: | 1.07 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.260 |
| Book Value | 0.280 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -45.0 |
| Return on Equity (ttm) | -82.3 |
Company news
Thu, 28 May 2026
Experimental osteoporosis pill gets late-breaking ENDO 2026 slot - Stock Titan
Tue, 26 May 2026
ENTX - Finviz
Sun, 17 May 2026
[EFFECT] Entera Bio Ltd. SEC Filing - Stock Titan
Fri, 08 May 2026
Entera Bio (ENTX) grants COO 72,993 RSUs in lieu of cash bonus - Stock Titan
Wed, 29 Apr 2026
Entera Bio (ENTX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Fri, 24 Apr 2026
Leading Osteoporosis Experts Are Lining Up Behind Entera Bio (NASDAQ: ENTX) - TradingView
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
